/Equities/XLON/SN.

Smith Nephew PLC

/Equities/XLON/SN.

Smith Nephew PLC

Loading price data...

--

Price Chart

Open: 1229.50
High: 1234.50
Low: 1216.00
Close: 1222.50
Change: -4.50 (-0.37%)
Volume: 358,845

Recent RNS announcements

2 Apr 2026	09:36:44	Director/PDMR Shareholding
1 Apr 2026	12:23:28	Total Voting Rights
24 Mar 2026	16:16:54	Director/PDMR Shareholding
24 Mar 2026	08:45:18	Holding(s) in Company

Annual Reports

16 Mar 2026	Annual Report
16 Mar 2026	Annual Financial and Audit Reports
10 Mar 2025	Annual Financial and Audit Reports

Directors (20+)

RC

Rupert Christopher SoamesChair

3 yrs

AD

Ajay DhankharCHIEF STRATEGY & CORPORATE DEVELOPMENT OFFICER

–

MK

Mizanu KebedeCHIEF QUALITY & REGULATORY AFFAIRS OFFICER

–

AP

Alison ParkesCHIEF COMPLIANCE OFFICER

–

AS

Angela Susan RisleyNon-Executive Director

8 yrs 7 mos

In the Press

30 Mar 2026	Medtech faces greatest polymer cost pressure as oil prices rise, says Deutsche Bank	Proactive Investors
10 Mar 2026	FTSE 100 rallies as inflation fears ease	The Independent

Company details

Smith & Nephew creates innovative technology that enables people to live without limitations. We assist healthcare professionals in restoring their patients' health and mobility, empowering them to achieve their maximum potential.

Industry: Health Care
Sector: Health Care
LEI: 213800ZTMDN8S67S1H61
Region: Europe
Admission date: 23 Feb 1937
Website: www.smith-nephew.com
X: @SmithNephewPLC

Shares details

Shares in issue: 877,733,750
Total Voting Rights: 853,971,798
Treasury Shares: 23,761,952

Loading price data...

--

Price Chart

Open: 1229.50
High: 1234.50
Low: 1216.00
Close: 1222.50
Change: -4.50 (-0.37%)
Volume: 358,845

Recent RNS announcements

2 Apr 2026	09:36:44	Director/PDMR Shareholding
1 Apr 2026	12:23:28	Total Voting Rights
24 Mar 2026	16:16:54	Director/PDMR Shareholding
24 Mar 2026	08:45:18	Holding(s) in Company

Annual Reports

16 Mar 2026	Annual Report
16 Mar 2026	Annual Financial and Audit Reports
10 Mar 2025	Annual Financial and Audit Reports

Directors (20+)

RC

Rupert Christopher SoamesChair

3 yrs

AD

Ajay DhankharCHIEF STRATEGY & CORPORATE DEVELOPMENT OFFICER

–

MK

Mizanu KebedeCHIEF QUALITY & REGULATORY AFFAIRS OFFICER

–

AP

Alison ParkesCHIEF COMPLIANCE OFFICER

–

AS

Angela Susan RisleyNon-Executive Director

8 yrs 7 mos

In the Press

30 Mar 2026	Medtech faces greatest polymer cost pressure as oil prices rise, says Deutsche Bank	Proactive Investors
10 Mar 2026	FTSE 100 rallies as inflation fears ease	The Independent

Company details

Smith & Nephew creates innovative technology that enables people to live without limitations. We assist healthcare professionals in restoring their patients' health and mobility, empowering them to achieve their maximum potential.

Industry: Health Care
Sector: Health Care
LEI: 213800ZTMDN8S67S1H61
Region: Europe
Admission date: 23 Feb 1937
Website: www.smith-nephew.com
X: @SmithNephewPLC

Shares details

Shares in issue: 877,733,750
Total Voting Rights: 853,971,798
Treasury Shares: 23,761,952

Last updated: 9 April 2026

Parliament Interests

Baroness Noakes has interests in this issuer

Recent Buybacks

12/08/2025

666,974£9.02M

11/08/2025

5,158£69,361

08/08/2025

526,803£7.07M

07/08/2025

320,207£4.32M

06/08/2025

414,772£5.55M

Instrument details

ISIN: GB0009223206
Exchange: XLON
Market: Main Market
Market Segment: SET1
Market Sector: FS10
Security Description: Ordinary Shares of USD0.20 each; fully paid
Listing Category: Equity shares (commercial companies)